Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models.

Graft-versus-host disease is a major complication after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Immunosuppressive drugs, such as anti-thymocyte globulin, alemtuzumab, and post-transplant cyclophosphamide, have been used to prevent graft-versus-host disease...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kiyomi Mashima, Iekuni Oh, Ken Fujiwara, Junko Izawa, Norihito Takayama, Hirofumi Nakano, Yasufumi Kawasaki, Daisuke Minakata, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Ken Ohmine, Shin-Ichiro Fujiwara, Nobuhiko Ohno, Yoshinobu Kanda
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Public Library of Science (PLoS) 2021-01-01
coleção:	PLoS ONE
Acesso em linha:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0245232&type=printable
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!